Abstract: The present invention concerns a compound having the following formula (I): as well as its use as a medicament, especially for its use for treating viral infections.
Type:
Grant
Filed:
April 23, 2019
Date of Patent:
March 14, 2023
Assignees:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, UNIVERSITE D'ORLEANS, NEOVIRTECH
Inventors:
Luigi Agrofoglio, Vincent Roy, Coralie De Schutter, Maxime Bessieres, Franck Gallardo